Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03689894
What this trial is testing

Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT

Who this might be right for
Chronic Graft-versus-host-disease
Dartmouth-Hitchcock Medical Center 2
Large-scale testing (Phase 3)UnknownNCT04713956
What this trial is testing

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 242
Large-scale testing (Phase 3)Active Not RecruitingNCT06149403
What this trial is testing

Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCT

Who this might be right for
MPS-IH (Hurler Syndrome)
Orchard Therapeutics 41
Post-approval studies (Phase 4)UnknownNCT01379391
What this trial is testing

Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationMyeloablativeDelayed Platelet Engraftment
Nanfang Hospital, Southern Medical University 80
Testing effectiveness (Phase 2)Enrolling By InvitationNCT02646839
What this trial is testing

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes
Michael Pulsipher 50
Testing effectiveness (Phase 2)UnknownNCT06348602
What this trial is testing

Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

Who this might be right for
Ocular Graft-versus-host Disease
Hospital Universitario Dr. Jose E. Gonzalez 60
Not applicableLooking for participantsNCT06458244
What this trial is testing

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Who this might be right for
Acute Myeloid Leukemia
Ruijin Hospital 90
Not applicableUnknownNCT06279585
What this trial is testing

Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD

Who this might be right for
Graft-versus-host-diseaseGraft Versus Host Disease, ChronicStem Cell Transplant Complications+2 more
University of Seville 108
Not applicableUnknownNCT03616015
What this trial is testing

Dysbiosis and Immune Reconstitution After Allo-HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantation
Central Hospital, Nancy, France 80
Testing effectiveness (Phase 2)Study completedNCT01772953
What this trial is testing

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Center for International Blood and Marrow Transplant Research 40
Large-scale testing (Phase 3)Study completedNCT02942173
What this trial is testing

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Testing effectiveness (Phase 2)WithdrawnNCT05604742
What this trial is testing

Belimumab for Treatment of cGVHD Following Allo-HCT

Who this might be right for
cGVHD
xuna
Large-scale testing (Phase 3)Not Yet RecruitingNCT07052422
What this trial is testing

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Who this might be right for
Older PatientsMyeloid MalignanciesConditioning+1 more
Nanfang Hospital, Southern Medical University 160
Early research (Phase 1)UnknownNCT03114670
What this trial is testing

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Who this might be right for
Adult Acute Myeloid Leukemia
Affiliated Hospital to Academy of Military Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Not applicableLooking for participantsNCT05772273
What this trial is testing

PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 43
Large-scale testing (Phase 3)Study completedNCT02474290
What this trial is testing

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

Who this might be right for
Acute Myeloid LeukemiaHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 202
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Large-scale testing (Phase 3)Looking for participantsNCT06895538
What this trial is testing

Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

Who this might be right for
LeukemiaMDSLymphoma
Peking University First Hospital 24
Testing effectiveness (Phase 2)Ended earlyNCT04731298
What this trial is testing

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.

Who this might be right for
Graft Failure
Swedish Orphan Biovitrum 2
Next Page